Centre de Référence Maladies Rares

U1035 INSERM

Biotherapy of genetic diseases, inflammatory disorders and cancer (BMGIC)

FR: Biologie Fondamentale Appliquée à la Médecine

U1035Display navigation projects FR / EN

Hypoxia Platform
Project H1

Hypoxia Platform

keywords: hypoxia, tumor niche modeling, CellOxia

Description:

Hypoxia Platform CellOxia

Contact

Arnaud VILLACRECES (arnaud.villacreces@u-bordeaux.fr)

→ Consulter le planning réservation

Related publications:

  • Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence Angela Ianniciello,* Pierre-Yves Dumas,* Claire Drullion,* Amélie Guitart, Arnaud Villacreces, Yan Peytour, Jean Chevaleyre, Philippe Brunet de la Grange, Isabelle Vigon, Vanessa Desplat, Muriel Priault, Persio Dello Sbarba, Zoran Ivanovic, François-Xavier Mahon, and Jean-Max Pasquet *These authors contributed equally to this work Oncotarget (2017-06) 14; 8(57): 96984–96992
  • Hypoxia/hypercapniainduced adaptation maintains functional capacity of cord blood stem and progenitor cells at 4°C. Vlaski M, Negroni L, Kovacevic-Filipovic M, Guibert C, Brunet de la Grange P, Rossignol R, Chevaleyre J, Duchez P, Lafarge X, Praloran V, Schmitter JM, Ivanovic Z. J Cell Physiol. (2014-12) J Cell Physiol.

Back to team's projects

INSERM U1035! - University of Bordeaux
Work
146 rue Léo Saignat - PE building south zone, 4th floor
33000 Bordeaux
Aquitaine
France
Work +33 557 57 13 73/74
sarah.lesjean@inserm.fr